Consequently, the expression of phosphorylated β-catenin at Ser37 was significantly increased in both small intestinal and colonic polyps following modulation of GSK-3β by myricetin (p < 0.01 vs. vehicle control). The gene discussed is GSK3B; the disease is polyp of colon.